<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Depression Symptoms Treatment &#187; Antidepressants</title>
	<atom:link href="http://depressionsymptomstreatment.net/category/antidepressants/feed/" rel="self" type="application/rss+xml" />
	<link>http://depressionsymptomstreatment.net</link>
	<description></description>
	<lastBuildDate>Mon, 06 Feb 2012 13:38:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>Sertraline Hydrochlonde</title>
		<link>http://depressionsymptomstreatment.net/antidepressants/zoloft-sertraline/sertraline-hydrochlonde/</link>
		<comments>http://depressionsymptomstreatment.net/antidepressants/zoloft-sertraline/sertraline-hydrochlonde/#comments</comments>
		<pubDate>Sat, 25 Dec 2010 06:05:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Zoloft (Sertraline)]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[anxiety disorders]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[Dial]]></category>
		<category><![CDATA[Fluoxetine]]></category>
		<category><![CDATA[headache]]></category>
		<category><![CDATA[obsessive-compulsive disorder]]></category>
		<category><![CDATA[Orap]]></category>
		<category><![CDATA[panic disorder]]></category>
		<category><![CDATA[phobic disorders]]></category>
		<category><![CDATA[post-traumatic stress disorder]]></category>
		<category><![CDATA[Sertraline]]></category>
		<category><![CDATA[SSRIs]]></category>
		<category><![CDATA[Zoloft]]></category>

		<guid isPermaLink="false">http://depressionsymptomstreatment.net/?p=1094</guid>
		<description><![CDATA[Drug Approvals (British Approved Name Modified, US Adopted Name, rINN) International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish): Synonyms: CP-51974-01; CP-51974-1; Sertralina, hidrocloruro de BAN: Sertraline Hydrochloride [BANM] USAN: Sertraline Hydrochloride INN: Sertraline Hydrochloride [rINNM (en)] INN: Hidrocloruro de sertralina [rINNM (es)] INN: Sertraline, Chlorhydrate de [rINNM (fr)] INN: Sertralini Hydrochloridum [rINNM (la)] INN: Сертралина Гидрохлорид [rINNM (ru)] Chemical name: (1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthyl(methyl)amine hydrochloride Molecular formula: C17H17Cl2N,HCl =342.7 CAS: 79617-96-2 (sertraline); 79559-97-0 (sertraline hydrochloride) ATC code: N06AB06 Note. The following terms have been used as 'street names' or slang names for various forms of sertraline: Z's Zloft Zoomers. Pharmacopoeias. In Europe. European Pharmacopoeia, 6th ed. (Sertraline Hydrochlonde). A white or almost white, crystalline powder, ft exhibits polymorphism. Slightly soluble in water freely soluble in anhydrous alcohol Read more [...]]]></description>
			<content:encoded><![CDATA[Drug Approvals
(British Approved Name Modified, US Adopted Name, rINN)

International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish):
Synonyms: CP-51974-01; CP-51974-1; Sertralina,  hidrocloruro de
BAN: Sertraline Hydrochloride [BANM]
USAN: Sertraline Hydrochloride
INN: Sertraline Hydrochloride [rINNM (en)]
INN: Hidrocloruro de sertralina [rINNM (es)]
INN: Sertraline, Chlorhydrate de [rINNM (fr)]
INN: Sertralini Hydrochloridum [rINNM (la)]
INN: Сертралина Гидрохлорид [rINNM (ru)]
Chemical name:  (1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthyl(methyl)amine  hydrochloride
Molecular formula: C17H17Cl2N,HCl =342.7
CAS: 79617-96-2 (sertraline); 79559-97-0 (sertraline  hydrochloride)
ATC code: N06AB06
Note. The following terms have been used as 'street names' or slang names for various forms of sertraline: Z's Zloft Zoomers.

Pharmacopoeias. In Europe.

European Pharmacopoeia, 6th ed. (Sertraline Hydrochlonde). A white or almost white, crystalline powder, ft exhibits polymorphism. Slightly soluble in water freely soluble in anhydrous alcohol <a href="http://depressionsymptomstreatment.net/antidepressants/zoloft-sertraline/sertraline-hydrochlonde/" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://depressionsymptomstreatment.net/antidepressants/zoloft-sertraline/sertraline-hydrochlonde/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Reboxetine Mesilate</title>
		<link>http://depressionsymptomstreatment.net/antidepressants/reboxetine-mesilate/</link>
		<comments>http://depressionsymptomstreatment.net/antidepressants/reboxetine-mesilate/#comments</comments>
		<pubDate>Wed, 22 Dec 2010 05:57:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Antidepressants]]></category>
		<category><![CDATA[Ability]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[anxiety disorders]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[coma]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[epilepsy]]></category>
		<category><![CDATA[Fluoxetine]]></category>
		<category><![CDATA[Fluvoxamine]]></category>
		<category><![CDATA[Luvox]]></category>
		<category><![CDATA[orthostatic hypotension]]></category>
		<category><![CDATA[panic disorder]]></category>
		<category><![CDATA[Phenelzine]]></category>
		<category><![CDATA[Reboxetine]]></category>
		<category><![CDATA[SSRIs]]></category>
		<category><![CDATA[stroke]]></category>

		<guid isPermaLink="false">http://depressionsymptomstreatment.net/?p=1091</guid>
		<description><![CDATA[Drug Nomenclature Synonyms: FCE-20124 (reboxetine or reboxetine mesilate); PNU-155950E; Reboxetina, mesilato de; Reboxetine Mesylate BAN: Reboxetine Mesilate [BANM] USAN: Reboxetine Mesylate INN: Reboxetine Mesilate [rINNM (en)] INN: Mesilato de reboxetina [rINNM (es)] INN: Réboxétine, Mésilate de [rINNM (fr)] INN: Reboxetini Mesilas [rINNM (la)] INN: Ребоксетина Мезилат [rINNM (ru)] Chemical name: (±)-(2RS)-2-[(αRS)-α(2-Ethoxyphenoxy)benzyl]morpholine methanesulphonate Molecular formula: C19H23NO3,CH4O3S =409.5 CAS: 71620-89-8; 98769-81-4 (both reboxetine); 98769-82-5; 98769-84-7 (both reboxetine mesilate) ATC code: N06AX18 Adverse Effects Adverse effects most commonly seen with reboxetine include insomnia, dry mouth, constipation, and increased sweating. Disturbance of visual accommodation, loss of appetite, vertigo, tachycardia, palpitations, vasodilatation, orthostatic hypotension, urinary hesitancy or retention (mainly in men), and erectile dysfunction including ejaculatory delay are also reported as being common adverse reactions. There have been reports of allergic Read more [...]]]></description>
			<content:encoded><![CDATA[Drug Nomenclature

Synonyms: FCE-20124 (reboxetine or reboxetine  mesilate); PNU-155950E; Reboxetina, mesilato de; Reboxetine Mesylate
BAN: Reboxetine Mesilate [BANM]
USAN: Reboxetine Mesylate
INN: Reboxetine Mesilate [rINNM (en)]
INN: Mesilato de reboxetina [rINNM (es)]
INN: Réboxétine, Mésilate de [rINNM (fr)]
INN: Reboxetini Mesilas [rINNM (la)]
INN: Ребоксетина Мезилат [rINNM (ru)]
Chemical name:  (±)-(2RS)-2-[(αRS)-α(2-Ethoxyphenoxy)benzyl]morpholine  methanesulphonate
Molecular formula: C19H23NO3,CH4O3S =409.5
CAS: 71620-89-8; 98769-81-4 (both reboxetine);  98769-82-5; 98769-84-7 (both reboxetine mesilate)
ATC code: N06AX18

Adverse Effects
Adverse effects most commonly seen with reboxetine include insomnia, dry mouth, constipation, and increased sweating. Disturbance of visual accommodation, loss of appetite, vertigo, tachycardia, palpitations, vasodilatation, orthostatic hypotension, urinary hesitancy or retention (mainly in men), and erectile dysfunction including ejaculatory delay are also reported as being common adverse reactions. There have been reports of allergic <a href="http://depressionsymptomstreatment.net/antidepressants/reboxetine-mesilate/" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://depressionsymptomstreatment.net/antidepressants/reboxetine-mesilate/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protriptyline Hydrochloride</title>
		<link>http://depressionsymptomstreatment.net/antidepressants/protriptyline-hydrochloride/</link>
		<comments>http://depressionsymptomstreatment.net/antidepressants/protriptyline-hydrochloride/#comments</comments>
		<pubDate>Sun, 19 Dec 2010 05:43:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Antidepressants]]></category>
		<category><![CDATA[Amitriptyline]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[orthostatic hypotension]]></category>
		<category><![CDATA[Protriptyline]]></category>
		<category><![CDATA[Tricyclic Antidepressants]]></category>
		<category><![CDATA[Vivactil]]></category>

		<guid isPermaLink="false">http://depressionsymptomstreatment.net/?p=1089</guid>
		<description><![CDATA[Drug Nomenclature Synonyms: MK-240; Protriptilina, hidrocloruro de BAN: Protriptyline Hydrochloride [BANM] USAN: Protriptyline Hydrochloride INN: Protriptyline Hydrochloride [rINNM (en)] INN: Hidrocloruro de protriptilina [rINNM (es)] INN: Protriptyline, Chlorhydrate de [rINNM (fr)] INN: Protriptylini Hydrochloridum [rINNM (la)] INN: Протриптилина Гидрохлорид [rINNM (ru)] Chemical name: 3-(5H-Dibenzo[a,d]cyclohept-5-enyl)propyl(methyl)amine hydrochloride Molecular formula: C19H21N,HCl =299.8 CAS: 438-60-8 (protriptyline); 1225-55-4 (protriptyline hydrochloride) ATC code: N06AA11 Read code: y025a Pharmacopoeias. In British and US. BP 2008 (Protriptyline Hydrochloride). A white to yellowish-white, odourless or almost odourless, powder. Freely soluble in water, in alcohol, and in chloroform practically insoluble in ether A 1% solution in water has a pH of 5.0 to 6.5. The United States Pharmacopeia 31, 2008 (Protriptyline Hydrochloride). A white to yellowish powder. Is odourless or has not more than a slight odour. Soluble 1 in 2 of water, 1 in 3.5 of alcohol, and Read more [...]]]></description>
			<content:encoded><![CDATA[Drug Nomenclature

Synonyms: MK-240; Protriptilina, hidrocloruro de
BAN: Protriptyline  Hydrochloride [BANM]
USAN: Protriptyline  Hydrochloride
INN: Protriptyline  Hydrochloride [rINNM (en)]
INN: Hidrocloruro de protriptilina [rINNM  (es)]
INN: Protriptyline,  Chlorhydrate de [rINNM (fr)]
INN: Protriptylini Hydrochloridum [rINNM (la)]
INN: Протриптилина Гидрохлорид [rINNM (ru)]
Chemical name:  3-(5H-Dibenzo[a,d]cyclohept-5-enyl)propyl(methyl)amine  hydrochloride
Molecular formula: C19H21N,HCl =299.8
CAS: 438-60-8 (protriptyline); 1225-55-4 (protriptyline hydrochloride)
ATC code: N06AA11
Read code: y025a

Pharmacopoeias. In British and US.

BP 2008 (Protriptyline Hydrochloride). A white to yellowish-white, odourless or almost odourless, powder. Freely soluble in water, in alcohol, and in chloroform practically insoluble in ether A 1% solution in water has a pH of 5.0 to 6.5.

The United States Pharmacopeia 31, 2008 (Protriptyline Hydrochloride). A white to yellowish powder. Is odourless or has not more than a slight odour. Soluble 1 in 2 of water, 1 in 3.5 of alcohol, and <a href="http://depressionsymptomstreatment.net/antidepressants/protriptyline-hydrochloride/" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://depressionsymptomstreatment.net/antidepressants/protriptyline-hydrochloride/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nortriptyline Hydrochloride</title>
		<link>http://depressionsymptomstreatment.net/antidepressants/nortriptyline-hydrochloride/</link>
		<comments>http://depressionsymptomstreatment.net/antidepressants/nortriptyline-hydrochloride/#comments</comments>
		<pubDate>Thu, 16 Dec 2010 12:26:38 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Antidepressants]]></category>
		<category><![CDATA[Ability]]></category>
		<category><![CDATA[Amitriptyline]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[Aventyl]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[Nortriptyline]]></category>
		<category><![CDATA[Pamelor]]></category>
		<category><![CDATA[Tricyclic Antidepressants]]></category>

		<guid isPermaLink="false">http://depressionsymptomstreatment.net/?p=1080</guid>
		<description><![CDATA[Drug Approvals (British Approved Name Modified, US Adopted Name, rINN) International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish): Synonyms: 38489; Nortriptilin-hidroklorid; Nortriptilina, hidrocloruro de; Nortriptilino hidrochloridas; Nortriptyliinihydrokloridi; Nortriptylin-hydrochlorid; Nortriptylinhydroklorid; Nortriptylini Hydrochloridum BAN: Nortriptyline Hydrochloride [BANM] USAN: Nortriptyline Hydrochloride INN: Nortriptyline Hydrochloride [rINNM (en)] INN: Hidrocloruro de nortriptilina [rINNM (es)] INN: Nortriptyline, Chlorhydrate de [rINNM (fr)] INN: Nortriptylini Hydrochloridum [rINNM (la)] INN: Нортриптилина Гидрохлорид [rINNM (ru)] Chemical name: 3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)propyl(methyl)amine hydrochloride Molecular formula: C19H21N,HCl =299.8 CAS: 72-69-5 (nortriptyline); 894-71-3 (nortriptyline hydrochloride) ATC code: N06AA10 Read code: y00VT [Enuresis] Pharmacopoeias. In Europe, Japan, and US. European Pharmacopoeia, 6th ed. (Nortriptyline Hydrochloride). A white or almost white powder. Sparingly Read more [...]]]></description>
			<content:encoded><![CDATA[Drug Approvals
(British Approved Name Modified, US Adopted Name, rINN)

International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish):
Synonyms: 38489;  Nortriptilin-hidroklorid; Nortriptilina, hidrocloruro de; Nortriptilino  hidrochloridas; Nortriptyliinihydrokloridi; Nortriptylin-hydrochlorid;  Nortriptylinhydroklorid; Nortriptylini Hydrochloridum
BAN: Nortriptyline Hydrochloride [BANM]
USAN: Nortriptyline Hydrochloride
INN: Nortriptyline Hydrochloride [rINNM (en)]
INN: Hidrocloruro de nortriptilina [rINNM  (es)]
INN: Nortriptyline, Chlorhydrate de [rINNM  (fr)]
INN: Nortriptylini Hydrochloridum [rINNM (la)]
INN: Нортриптилина Гидрохлорид [rINNM (ru)]
Chemical name: 3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)propyl(methyl)amine hydrochloride
Molecular formula: C19H21N,HCl =299.8
CAS: 72-69-5 (nortriptyline); 894-71-3 (nortriptyline hydrochloride)
ATC code: N06AA10
Read code: y00VT [Enuresis]
Pharmacopoeias. In Europe, Japan, and US.

European Pharmacopoeia, 6th ed. (Nortriptyline Hydrochloride). A white or almost white powder. Sparingly <a href="http://depressionsymptomstreatment.net/antidepressants/nortriptyline-hydrochloride/" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://depressionsymptomstreatment.net/antidepressants/nortriptyline-hydrochloride/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fluvoxamine Maleate</title>
		<link>http://depressionsymptomstreatment.net/antidepressants/fluvoxamine-maleate/</link>
		<comments>http://depressionsymptomstreatment.net/antidepressants/fluvoxamine-maleate/#comments</comments>
		<pubDate>Sun, 12 Dec 2010 12:19:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Antidepressants]]></category>
		<category><![CDATA[Ability]]></category>
		<category><![CDATA[anxiety disorders]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[Floxyfral]]></category>
		<category><![CDATA[Fluoxetine]]></category>
		<category><![CDATA[Fluvoxamine]]></category>
		<category><![CDATA[headache]]></category>
		<category><![CDATA[hypochondriasis]]></category>
		<category><![CDATA[Luvox]]></category>
		<category><![CDATA[obsessive-compulsive disorder]]></category>
		<category><![CDATA[panic disorder]]></category>
		<category><![CDATA[phobic disorders]]></category>
		<category><![CDATA[SSRIs]]></category>
		<category><![CDATA[tremor]]></category>

		<guid isPermaLink="false">http://depressionsymptomstreatment.net/?p=1076</guid>
		<description><![CDATA[Drug Nomenclature Synonyms: DU-23000; Fluvoksamiinimaleaatti; Fluvoxamina, maleato de; Fluvoxamini Maleas; Fluvoxaminmaleat BAN: Fluvoxamine Maleate [BANM] USAN: Fluvoxamine Maleate INN: Fluvoxamine Maleate [rINNM (en)] INN: Maleato de fluvoxamina [rINNM (es)] INN: Fluvoxamine, Maléate de [rINNM (fr)] INN: Fluvoxamini Maleas [rINNM (la)] INN: Флувоксамина Малеат [rINNM (ru)] Chemical name: (E)-5-Methoxy-4´-trifluoromethylvalerophenone O-2-aminoethyloxime maleate Molecular formula: C15H21F3N2O2,C4H4O4 =434.4 CAS: 54739-18-3 (fluvoxamine); 61718-82-9 (fluvoxamine maleate) ATC code: N06AB08 Read code: y026Z Pharmacopoeias. In Europe and US. European Pharmacopoeia, 6th ed. (Fluvoxamine Maleate). A white or almost white, crystalline powder. Sparingly soluble in water freely soluble in alcohol and in methyl alcohol. The United States Pharmacopeia 31, 2008 (Fluvoxamine Maleate). A white to off-white, crystalline powder. Sparingly soluble in water freely soluble in alcohol and in chloroform practically insoluble in solvent ether. Protect from light. Adverse Effects, Treatment, and Read more [...]]]></description>
			<content:encoded><![CDATA[Drug Nomenclature

Synonyms: DU-23000; Fluvoksamiinimaleaatti; Fluvoxamina, maleato de;  Fluvoxamini Maleas; Fluvoxaminmaleat
BAN: Fluvoxamine Maleate [BANM]
USAN: Fluvoxamine Maleate
INN: Fluvoxamine Maleate [rINNM (en)]
INN: Maleato de fluvoxamina [rINNM (es)]
INN: Fluvoxamine, Maléate de [rINNM (fr)]
INN: Fluvoxamini Maleas [rINNM (la)]
INN: Флувоксамина Малеат [rINNM (ru)]
Chemical name: (E)-5-Methoxy-4´-trifluoromethylvalerophenone O-2-aminoethyloxime maleate
Molecular formula: C15H21F3N2O2,C4H4O4 =434.4
CAS: 54739-18-3 (fluvoxamine); 61718-82-9 (fluvoxamine maleate)
ATC code: N06AB08
Read code: y026Z

Pharmacopoeias. In Europe and US.

European Pharmacopoeia, 6th ed. (Fluvoxamine Maleate). A white or almost white, crystalline powder. Sparingly soluble in water freely soluble in alcohol and in methyl alcohol.

The United States Pharmacopeia 31, 2008 (Fluvoxamine Maleate). A white to off-white, crystalline powder. Sparingly soluble in water freely soluble in alcohol and in chloroform practically insoluble in solvent ether. Protect from light.
Adverse Effects, Treatment, and <a href="http://depressionsymptomstreatment.net/antidepressants/fluvoxamine-maleate/" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://depressionsymptomstreatment.net/antidepressants/fluvoxamine-maleate/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Paroxetine</title>
		<link>http://depressionsymptomstreatment.net/antidepressants/paxil-paroxetine/paroxetine/</link>
		<comments>http://depressionsymptomstreatment.net/antidepressants/paxil-paroxetine/paroxetine/#comments</comments>
		<pubDate>Thu, 09 Dec 2010 13:22:45 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Paxil (Paroxetine)]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[anxiety disorders]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[dystonias]]></category>
		<category><![CDATA[Fluoxetine]]></category>
		<category><![CDATA[hypochondriasis]]></category>
		<category><![CDATA[obsessive-compulsive disorder]]></category>
		<category><![CDATA[Orap]]></category>
		<category><![CDATA[panic disorder]]></category>
		<category><![CDATA[Paroxetine]]></category>
		<category><![CDATA[Paroxetine mesylate]]></category>
		<category><![CDATA[Paxil]]></category>
		<category><![CDATA[Pexeva]]></category>
		<category><![CDATA[phobic disorders]]></category>
		<category><![CDATA[post-traumatic stress disorder]]></category>
		<category><![CDATA[SSRIs]]></category>

		<guid isPermaLink="false">http://depressionsymptomstreatment.net/?p=1084</guid>
		<description><![CDATA[Drug Approvals (British Approved Name, US Adopted Name, rINN) INNs in other languages (French, Latin, and Spanish): Synonyms: BRL-29060; FG-7051; Paroksetiini; Paroxetin; Paroxetinum BAN: Paroxetine USAN: Paroxetine INN: Paroxetine [rINN (en)] INN: Paroxetina [rINN (es)] INN: Paroxétine [rINN (fr)] INN: Paroxetinum [rINN (la)] INN: Пароксетин [rINN (ru)] Chemical name: (-)-trans-5-(4-p-Fluorophenyl-3-piperidylmethoxy)-1,3-benzodioxole Molecular formula: C19H20FNO3 =329.4 CAS: 61869-08-7 ATC code: N06AB05 Paroxetine Hydrochloride Drug Approvals (British Approved Name Modified, rINNM) International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish): Synonyms: BRL-29060A; Paroksetiinihydrokloridihemihydraatti; Paroksetino hidrochloridas hemihidratas; Paroxetin hydrochlorid; Paroxetina, hidrocloruro de; Paroxetine Hydrochloride Hemihydrate; Paroxetinhydrokloridhemihydrat; Paroxetini Hydrochloridum; Paroxetini Hydrochloridum Hemihydricum BAN: Paroxetine Hydrochloride [BANM] INN: Paroxetine Hydrochloride [rINNM (en)] INN: Hidrocloruro de paroxetina [rINNM (es)] INN: Read more [...]]]></description>
			<content:encoded><![CDATA[Drug Approvals
(British Approved Name, US Adopted Name, rINN)

INNs in other languages (French, Latin, and Spanish):
Synonyms: BRL-29060; FG-7051; Paroksetiini;  Paroxetin; Paroxetinum
BAN: Paroxetine
USAN: Paroxetine
INN: Paroxetine [rINN (en)]
INN: Paroxetina [rINN (es)]
INN: Paroxétine [rINN (fr)]
INN: Paroxetinum [rINN (la)]
INN: Пароксетин [rINN (ru)]
Chemical name:  (-)-trans-5-(4-p-Fluorophenyl-3-piperidylmethoxy)-1,3-benzodioxole
Molecular formula: C19H20FNO3 =329.4
CAS: 61869-08-7
ATC code: N06AB05
Paroxetine Hydrochloride
Drug Approvals
(British Approved Name Modified, rINNM)

International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish):
Synonyms: BRL-29060A;  Paroksetiinihydrokloridihemihydraatti; Paroksetino hidrochloridas hemihidratas;  Paroxetin hydrochlorid; Paroxetina, hidrocloruro de; Paroxetine Hydrochloride  Hemihydrate; Paroxetinhydrokloridhemihydrat; Paroxetini Hydrochloridum;  Paroxetini Hydrochloridum Hemihydricum
BAN: Paroxetine Hydrochloride [BANM]
INN: Paroxetine Hydrochloride [rINNM (en)]
INN: Hidrocloruro de paroxetina [rINNM (es)]
INN: <a href="http://depressionsymptomstreatment.net/antidepressants/paxil-paroxetine/paroxetine/" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://depressionsymptomstreatment.net/antidepressants/paxil-paroxetine/paroxetine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Trazodone Hydrochloride</title>
		<link>http://depressionsymptomstreatment.net/antidepressants/trazodone-hydrochloride/</link>
		<comments>http://depressionsymptomstreatment.net/antidepressants/trazodone-hydrochloride/#comments</comments>
		<pubDate>Wed, 08 Dec 2010 11:11:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Antidepressants]]></category>
		<category><![CDATA[alzheimer's disease]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[Benzodiazepines]]></category>
		<category><![CDATA[bulimia nervosa]]></category>
		<category><![CDATA[Carbamazepine]]></category>
		<category><![CDATA[Clomipramine]]></category>
		<category><![CDATA[Clonidine]]></category>
		<category><![CDATA[Cocaine]]></category>
		<category><![CDATA[coma]]></category>
		<category><![CDATA[dementia]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[Desyrel]]></category>
		<category><![CDATA[Dial]]></category>
		<category><![CDATA[epilepsy]]></category>
		<category><![CDATA[headache]]></category>
		<category><![CDATA[MAOIs]]></category>
		<category><![CDATA[Methadone]]></category>
		<category><![CDATA[Nefazodone]]></category>
		<category><![CDATA[neuroleptic malignant syndrome]]></category>
		<category><![CDATA[orthostatic hypotension]]></category>
		<category><![CDATA[Pamine]]></category>
		<category><![CDATA[Phenelzine]]></category>
		<category><![CDATA[Phenytoin]]></category>
		<category><![CDATA[Piperazine]]></category>
		<category><![CDATA[SSRIs]]></category>
		<category><![CDATA[syncope]]></category>
		<category><![CDATA[Trazodone]]></category>
		<category><![CDATA[tremor]]></category>
		<category><![CDATA[Tricyclic Antidepressants]]></category>
		<category><![CDATA[Trittico]]></category>

		<guid isPermaLink="false">http://depressionsymptomstreatment.net/?p=1065</guid>
		<description><![CDATA[Drug Approvals (British Approved Name Modified, US Adopted Name, rINN) International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish): Synonyms: AF-1161; Trazodona, hidrocloruro de BAN: Trazodone Hydrochloride [BANM] USAN: Trazodone Hydrochloride INN: Trazodone Hydrochloride [rINNM (en)] INN: Hidrocloruro de trazodona [rINNM (es)] INN: Trazodone, Chlorhydrate de [rINNM (fr)] INN: Trazodoni Hydrochloridum [rINNM (la)] INN: Тразодона Гидрохлорид [rINNM (ru)] Chemical name: 2-[3-(4-m-Chlorophenylpiperazin-1-yl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochloride Molecular formula: C19H22ClN5O,HCl =408.3 CAS: 19794-93-5 (trazodone); 25332-39-2 (trazodone hydrochloride) ATC code: N06AX05 Read code: y025f Note. The following terms have been used as 'street names' (see p.vi) or slang names for various forms of trazodone hydrochloride: Sleepeasy. Pharmacopoeias. In British and US. BP 2008 (Trazodone Hydrochloride). A white or almost white crystalline powder. Soluble in water sparingly soluble in alcohol practically insoluble in ether. A 1% solution Read more [...]]]></description>
			<content:encoded><![CDATA[Drug Approvals
(British Approved Name Modified, US Adopted Name, rINN)

International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish):
Synonyms: AF-1161; Trazodona, hidrocloruro de
BAN: Trazodone Hydrochloride [BANM]
USAN: Trazodone Hydrochloride
INN: Trazodone Hydrochloride [rINNM (en)]
INN: Hidrocloruro de trazodona [rINNM (es)]
INN: Trazodone, Chlorhydrate de [rINNM (fr)]
INN: Trazodoni Hydrochloridum [rINNM (la)]
INN: Тразодона Гидрохлорид [rINNM (ru)]
Chemical name: 2-[3-(4-m-Chlorophenylpiperazin-1-yl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one  hydrochloride
Molecular formula: C19H22ClN5O,HCl =408.3
CAS: 19794-93-5 (trazodone); 25332-39-2 (trazodone hydrochloride)
ATC code: N06AX05
Read code: y025f
Note. The following terms have been used as 'street names' (see p.vi) or slang names for various forms of trazodone hydrochloride: Sleepeasy.

Pharmacopoeias. In British and US.

BP 2008 (Trazodone Hydrochloride). A white or almost white crystalline powder. Soluble in water sparingly soluble in alcohol practically insoluble in ether. A 1% solution <a href="http://depressionsymptomstreatment.net/antidepressants/trazodone-hydrochloride/" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://depressionsymptomstreatment.net/antidepressants/trazodone-hydrochloride/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fluoxetine Hydrochlonde. Uses. Preparations</title>
		<link>http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-uses-preparations/</link>
		<comments>http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-uses-preparations/#comments</comments>
		<pubDate>Fri, 27 Aug 2010 04:09:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Prozac (Fluoxetine)]]></category>
		<category><![CDATA[Ability]]></category>
		<category><![CDATA[anorexia nervosa]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[anxiety disorders]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[bulimia nervosa]]></category>
		<category><![CDATA[Citalopram]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[Desipramine]]></category>
		<category><![CDATA[diabetic neuropathy]]></category>
		<category><![CDATA[Dial]]></category>
		<category><![CDATA[Fluoxetine]]></category>
		<category><![CDATA[Fluvoxamine]]></category>
		<category><![CDATA[headache]]></category>
		<category><![CDATA[hypochondriasis]]></category>
		<category><![CDATA[Levodopa]]></category>
		<category><![CDATA[Luvox]]></category>
		<category><![CDATA[migraine]]></category>
		<category><![CDATA[obsessive-compulsive disorder]]></category>
		<category><![CDATA[Olanzapine]]></category>
		<category><![CDATA[Orap]]></category>
		<category><![CDATA[orthostatic hypotension]]></category>
		<category><![CDATA[panic disorder]]></category>
		<category><![CDATA[paraphilias]]></category>
		<category><![CDATA[parkinson's disease]]></category>
		<category><![CDATA[Paroxetine]]></category>
		<category><![CDATA[Phenelzine]]></category>
		<category><![CDATA[phobic disorders]]></category>
		<category><![CDATA[post-traumatic stress disorder]]></category>
		<category><![CDATA[Prozac]]></category>
		<category><![CDATA[Sarafem]]></category>
		<category><![CDATA[Sertraline]]></category>
		<category><![CDATA[SSRIs]]></category>
		<category><![CDATA[syncope]]></category>
		<category><![CDATA[Tricyclic Antidepressants]]></category>
		<category><![CDATA[Venlafaxine]]></category>

		<guid isPermaLink="false">http://depressionsymptomstreatment.net/?p=1040</guid>
		<description><![CDATA[Uses and Administration Prevention of the reuptake of monoamine transmitters such as serotonin, which potentiates their action in the brain, appears to be associated with antidepressant activity. SSRIs such as fluoxetine preferentially inhibit the reuptake of serotonin compared with noradrenaline, and have limited direct action at other neurotrans-mitter sites, including muscarinic receptors. They therefore cause fewer antimuscarinic or sedative adverse effects than the tricyclic antidepressants and are less cardiotoxic. Citalopram is the most selective of the SSRIs currently available, whereas paroxetine is the most potent. SSRIs provide an alternative to the tricyclics for the treatment of depression. As with the tricyclics, it may be several weeks before an antidepressant effect is seen. Once depression has then resolved, maintenance therapy should be continued for at least 4 to 6 months (12 months in the elderly) to avoid relapse on stopping therapy. Patients with a history of recurrent depression should continue to receive maintenance treatment for at least 5 years and possibly indefinitely. Some Read more [...]]]></description>
			<content:encoded><![CDATA[Uses and Administration
Prevention of the reuptake of monoamine transmitters such as serotonin, which potentiates their action in the brain, appears to be associated with antidepressant activity. SSRIs such as fluoxetine preferentially inhibit the reuptake of serotonin compared with noradrenaline, and have limited direct action at other neurotrans-mitter sites, including muscarinic receptors. They therefore cause fewer antimuscarinic or sedative adverse effects than the tricyclic antidepressants and are less cardiotoxic. Citalopram is the most selective of the SSRIs currently available, whereas paroxetine is the most potent.

SSRIs provide an alternative to the tricyclics for the treatment of depression. As with the tricyclics, it may be several weeks before an antidepressant effect is seen. Once depression has then resolved, maintenance therapy should be continued for at least 4 to 6 months (12 months in the elderly) to avoid relapse on stopping therapy. Patients with a history of recurrent depression should continue to receive maintenance treatment for at least 5 years and possibly indefinitely.

Some <a href="http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-uses-preparations/" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-uses-preparations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fluoxetine Hydrochlonde. Precautions. Interactions</title>
		<link>http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-precautions-interactions/</link>
		<comments>http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-precautions-interactions/#comments</comments>
		<pubDate>Thu, 26 Aug 2010 04:07:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Prozac (Fluoxetine)]]></category>
		<category><![CDATA[Ability]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[Antihistamines]]></category>
		<category><![CDATA[Atomoxetine]]></category>
		<category><![CDATA[Atropine]]></category>
		<category><![CDATA[Barbital]]></category>
		<category><![CDATA[Benzodiazepines]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[bulimia nervosa]]></category>
		<category><![CDATA[Buspirone]]></category>
		<category><![CDATA[Carbamazepine]]></category>
		<category><![CDATA[Chlorpromazine]]></category>
		<category><![CDATA[Citalopram]]></category>
		<category><![CDATA[Clomipramine]]></category>
		<category><![CDATA[Clozapine]]></category>
		<category><![CDATA[coma]]></category>
		<category><![CDATA[Cyproheptadine]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[Diazepam]]></category>
		<category><![CDATA[Dosulepin]]></category>
		<category><![CDATA[epilepsy]]></category>
		<category><![CDATA[Ergotamine]]></category>
		<category><![CDATA[Fentanyl]]></category>
		<category><![CDATA[Fluoxetine]]></category>
		<category><![CDATA[Fluvoxamine]]></category>
		<category><![CDATA[Galantamine]]></category>
		<category><![CDATA[headache]]></category>
		<category><![CDATA[Luvox]]></category>
		<category><![CDATA[MAOIs]]></category>
		<category><![CDATA[Methadone]]></category>
		<category><![CDATA[migraine]]></category>
		<category><![CDATA[Mirtazapine]]></category>
		<category><![CDATA[Nefazodone]]></category>
		<category><![CDATA[obsessive-compulsive disorder]]></category>
		<category><![CDATA[Olanzapine]]></category>
		<category><![CDATA[Oxcarbazepine]]></category>
		<category><![CDATA[Oxycodone]]></category>
		<category><![CDATA[Pamine]]></category>
		<category><![CDATA[panic disorder]]></category>
		<category><![CDATA[Paroxetine]]></category>
		<category><![CDATA[Phenelzine]]></category>
		<category><![CDATA[Phenobarbital]]></category>
		<category><![CDATA[Phenytoin]]></category>
		<category><![CDATA[Procyclidine]]></category>
		<category><![CDATA[Promazine]]></category>
		<category><![CDATA[Risperidone]]></category>
		<category><![CDATA[Selegiline]]></category>
		<category><![CDATA[Sertraline]]></category>
		<category><![CDATA[Sibutramine]]></category>
		<category><![CDATA[SSRIs]]></category>
		<category><![CDATA[Sumatriptan]]></category>
		<category><![CDATA[Tizanidine]]></category>
		<category><![CDATA[Tramadol]]></category>
		<category><![CDATA[Trazodone]]></category>
		<category><![CDATA[tremor]]></category>
		<category><![CDATA[Tricyclic Antidepressants]]></category>
		<category><![CDATA[Venlafaxine]]></category>
		<category><![CDATA[Zolmitriptan]]></category>
		<category><![CDATA[Zolpidem]]></category>

		<guid isPermaLink="false">http://depressionsymptomstreatment.net/?p=1038</guid>
		<description><![CDATA[Precautions Because of their epileptogenic effect SSRIs should be used with caution in patients with epilepsy or a history of such disorders (and should be avoided if the epilepsy is poorly controlled). Treatment should be stopped if seizures develop or when there is an increase in seizure frequency. Care is advised in patients receiving ECT as prolonged seizures have occurred rarely. SSRIs should also be used with caution in patients with cardiac disease or a history of bleeding disorders. Although SSRIs are preferred to tricyclics for the treatment of depression in patients with diabetes, they may alter glycaemic control and therefore caution is also warranted in diabetic subjects. SSRIs should be used with caution in patients with angle-closure glaucoma. Fluoxetine should be stopped in patients who develop a rash since systemic effects, possibly related to vasculitis, have occurred in such patients. Fluoxetine undergoes hepatic metabolism and should be used with caution and in reduced doses in patients with impaired hepatic function. Patients should be closely monitored during early therapy Read more [...]]]></description>
			<content:encoded><![CDATA[Precautions
Because of their epileptogenic effect SSRIs should be used with caution in patients with epilepsy or a history of such disorders (and should be avoided if the epilepsy is poorly controlled). Treatment should be stopped if seizures develop or when there is an increase in seizure frequency. Care is advised in patients receiving ECT as prolonged seizures have occurred rarely. SSRIs should also be used with caution in patients with cardiac disease or a history of bleeding disorders. Although SSRIs are preferred to tricyclics for the treatment of depression in patients with diabetes, they may alter glycaemic control and therefore caution is also warranted in diabetic subjects. SSRIs should be used with caution in patients with angle-closure glaucoma. Fluoxetine should be stopped in patients who develop a rash since systemic effects, possibly related to vasculitis, have occurred in such patients. Fluoxetine undergoes hepatic metabolism and should be used with caution and in reduced doses in patients with impaired hepatic function.

Patients should be closely monitored during early therapy <a href="http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-precautions-interactions/" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-precautions-interactions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fluoxetine Hydrochlonde. Adverse Effects</title>
		<link>http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-adverse-effects/</link>
		<comments>http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-adverse-effects/#comments</comments>
		<pubDate>Wed, 25 Aug 2010 04:05:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Prozac (Fluoxetine)]]></category>
		<category><![CDATA[Ability]]></category>
		<category><![CDATA[Amitriptyline]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[Antihistamines]]></category>
		<category><![CDATA[Bupropion]]></category>
		<category><![CDATA[Citalopram]]></category>
		<category><![CDATA[Clomipramine]]></category>
		<category><![CDATA[Clorazepate]]></category>
		<category><![CDATA[coma]]></category>
		<category><![CDATA[Cyproheptadine]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[Dial]]></category>
		<category><![CDATA[dystonias]]></category>
		<category><![CDATA[Escitalopram]]></category>
		<category><![CDATA[Fluoxetine]]></category>
		<category><![CDATA[Fluvoxamine]]></category>
		<category><![CDATA[headache]]></category>
		<category><![CDATA[Imipramine]]></category>
		<category><![CDATA[Luvox]]></category>
		<category><![CDATA[MAOIs]]></category>
		<category><![CDATA[Mirtazapine]]></category>
		<category><![CDATA[Nefazodone]]></category>
		<category><![CDATA[orthostatic hypotension]]></category>
		<category><![CDATA[panic attack]]></category>
		<category><![CDATA[Paroxetine]]></category>
		<category><![CDATA[Pimozide]]></category>
		<category><![CDATA[Sertraline]]></category>
		<category><![CDATA[SSRIs]]></category>
		<category><![CDATA[Temazepam]]></category>
		<category><![CDATA[tremor]]></category>
		<category><![CDATA[Tricyclic Antidepressants]]></category>
		<category><![CDATA[Venlafaxine]]></category>

		<guid isPermaLink="false">http://depressionsymptomstreatment.net/?p=1036</guid>
		<description><![CDATA[Drug Approvals (BANM, US Adopted Name, rINNM) International Nonproprietary Names (INNs) in main languages (French, Latin, Spanish): Synonyms: Fluoksetiinihydrokloridi; Fluoksetino hidrochloridas; Fluoxetin-hidroklorid; Fluoxetin-hydrochlorid; Fluoxetina, hidrocloruro de; Fluoxetinhydroklorid; Fluoxetini Hydrochloridum; LY-110140; Lilly-103472 BAN: Fluoxetine Hydrochloride [BANM] USAN: Fluoxetine Hydrochloride INN: Fluoxetine Hydrochloride [rINNM (en)] INN: Hidrocloruro de fluoxetina [rINNM (es)] INN: Fluoxétine, Chlorhydrate de [rINNM (fr)] INN: Fluoxetini Hydrochloridum [rINNM (la)] INN: Флуоксетина Гидрохлорид [rINNM (ru)] Chemical name: (±)-N-Methyl-3-phenyl-3-(α,α,α-trifluoro-p-tolyloxy)propylamine hydrochloride Molecular formula: C17H18F3NO,HCl =345.8 CAS: 54910-89-3 (fluoxetine); 59333-67-4 (fluoxetine hydrochloride) ATC code: N06AB03 Read code: y026e Note. The following terms have been used as 'street names' or slang names for various forms of fluoxetine: Distas; Green and whites; Greens; Limes; Pros; Zacs. Pharmacopoeias. In Europe and US. European Pharmacopoeia, Read more [...]]]></description>
			<content:encoded><![CDATA[Drug Approvals
(BANM, US Adopted Name, rINNM)

International Nonproprietary Names (INNs) in main languages (French, Latin, Spanish):
Synonyms: Fluoksetiinihydrokloridi; Fluoksetino  hidrochloridas; Fluoxetin-hidroklorid; Fluoxetin-hydrochlorid; Fluoxetina,  hidrocloruro de; Fluoxetinhydroklorid; Fluoxetini Hydrochloridum; LY-110140;  Lilly-103472
BAN: Fluoxetine Hydrochloride [BANM]
USAN: Fluoxetine Hydrochloride
INN: Fluoxetine Hydrochloride [rINNM (en)]
INN: Hidrocloruro de fluoxetina [rINNM (es)]
INN: Fluoxétine, Chlorhydrate de [rINNM (fr)]
INN: Fluoxetini Hydrochloridum [rINNM (la)]
INN: Флуоксетина Гидрохлорид [rINNM (ru)]
Chemical name: (±)-N-Methyl-3-phenyl-3-(α,α,α-trifluoro-p-tolyloxy)propylamine  hydrochloride
Molecular formula: C17H18F3NO,HCl =345.8
CAS: 54910-89-3 (fluoxetine); 59333-67-4 (fluoxetine  hydrochloride)
ATC code: N06AB03
Read code: y026e
Note. The following terms have been used as 'street names' or slang names for various forms of fluoxetine: Distas; Green and whites; Greens; Limes; Pros; Zacs.

Pharmacopoeias. In Europe and US.

European Pharmacopoeia, <a href="http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-adverse-effects/" class="more-link">Read more [...]</a>]]></content:encoded>
			<wfw:commentRss>http://depressionsymptomstreatment.net/antidepressants/prozac-fluoxetine/fluoxetine-hydrochlonde-adverse-effects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

